U.S. Micro-Solutions is Partnering with Quess 360 to Offer Targeted HD Wipe Sampling for USP <800> Compliance - Safer Surfaces, Smarter Monitoring!
USP <800> states the following: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).
SOME RECOMMENDED AREAS to be sampled:
- Front grille within the C-PEC
- Cart beside the C-PEC
- Passthrough
- Floor in front of the C-PEC
- Armrest of a patient treatment chair
Hazardous Drugs Tested
| Groups of drugs | Limit of detection (ng per paper) |
|---|---|
| Group 1F fluorouracil |
2 |
| Group 1M methotrexate |
1 |
| Group 2 cytarabine dacarbazine DOXOrubicin epirubicin gemcitabine melphalan |
2.5 0.5 10 10 0.5 1 |
| Group 3 cyclophosphamide DOCEtaxel etoposide ifosfamide irinotecan methotrexate PACLitaxel PEMEtrexed topotecan vinBLAStine vinCRIstine |
0.5 30 2 0.5 2 1 10 2 1 5 5 |
| Group 4 Platins: (CISplatin, oxaliplatin, CARBOplatin) |
0.5 |
| Group 5 All hazardous drugs in groups 1 to 4 |
0.5 |
- Contribute to the assessment of safe practices in the workplace.
- Evaluate potential HD exposure to staff (pharmacy, nursing, other personnel)
- Validate the effectiveness of decontamination procedures.
- Assess the level of compliance of current procedures.